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1 Abstract 
 
Systematic Toxicological Analysis is an ongoing challenge in forensic as well as in clinical 
toxicology. The development of new methods based on LC-MS has been in the focus of 
researchers during the last decade. In order to establish a routine toxicological 
screening, all factors influencing the procedure need to be identified. Beginning from 
the ionization process and acquisition settings to the reference library - multiple factors 
have to be evaluated. Moreover, reproducibility and transferability of spectra is another 
issue, yet without satisfying solution. 
Introduction: For the development of a screening procedure a Linear Ion Trap was used 
in combination with HPLC and the ToxID library. Special emphasis was put on all 
parameters influencing a screening, including instrument features as well as on issues 
evolving from the library search. The aim was to identify the main factors that have to 
be considered when establishing LC-MS for Systematic Toxicological Analysis based on 
the used linear Ion Trap.  
Material and Methods: The LTQ Velos (Thermo Fisher Scientific) was the MS used for 
this work, in combination with the RS 300 Ultimate HPLC (Dionex). A testmix with 13 
toxicologically relevant substances was used for individual experiments. Deuterated 
standards were used to detect changes in the retention times of the chromatographic 
system. Single substances or a mix of compounds were either directly infused or 
injected via on-line HPLC. Pretests for limit of detection tests were performed for the 
compounds of the testmix and two real samples were analyzed with the newly 
established method. Screening results were evaluated manually and with ToxID - a 
library search tool provided by Thermo Fisher Scientific. Additionally the screening 
software SmileMS (GeneBio) was used.  
Results and Discussion: The key-parameters for the creation of library spectra and 
consequently for practical screening are discussed, as well as the proper ionization 
settings for different applications. Several methods for multi-target- and general 
unknown screening were established and can be used for future routine analysis. 
Moreover, pitfalls for screening and library spectra creation were identified. For the 
methods, the number of scan events, dynamic exclusion settings, activation parameters 
and the importance of preselecting the targets are discussed. The Tox_Library and the 
search tools “ToxID” and “SmileMS” were evaluated and spectra were added for MS² 
and MS³. 
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2 Introduction 
 
"General unknown screening" - the analytical process that takes 
place when no prior information about possible toxic agents is 
available - is an ongoing challenge of forensic and clinical 
toxicology. This challenge has been addressed by a well-
planned, systematic analytical approach - systematic 
toxicological analysis (STA). In the field of forensic toxicology, 
STA is the application of an appropriate analytical strategy for 
the identification of potentially toxic compounds and their 
metabolites in biological samples. The process of STA includes 
sampling, sample preparation (isolation), differentiation, 
detection, as well as identification. Due to the serious legal 
consequences of forensic cases, particular emphasis must be 
placed on the quality and reliability of analytical results. 
(http://www.tiaft.org/node/53 on September 13th, 2011) 
 
This definition given by the TIAFT (The International Association of Forensic 
Toxicologists) outlines the problems evolving from screening biological samples for toxic 
compounds. Toxins from different kinds of origin can harm the human body - including 
inorganic, organic, volatile and fairly stable substances, thus presenting toxicologists 
with a broad range of difficulties. Finding appropriate methods for identification is a 
demanding task. Each substance has multiple ways of entering the body, different 
metabolism, kinetic and elimination. By systematically using all established methods for 
sampling, sample preparation, differentiation, detection and identification the 
likelihood to find as many substances as possible is increased. 
A method routinely used for toxicological analysis is Mass Spectrometry (MS). This very 
sensitive method detects ionized molecules. When additional fragmentation is applied, 
the path of dissociation for each substance is similarly unique to a fingerprint. Coupled 
with distinct sample separation techniques such as High Performance Liquid 
Chromatography (HPLC) or Gas Chromatography (GC), MS is one of the most frequently 
used techniques in forensic toxicology (Gergov, Weinmann et al. 2004; Mueller, Duretz 
et al. 2011). 
Per definition, a “General Unknown Screening” (GUS) would include the search for ALL 
possible substances. However some compounds are not detectable by MS; others could 
be detected but are not found due to other reasons, such as the lack of the 
corresponding reference. Therefore Systematic Toxicological Analysis is performed. The 
systematic step-by-step approach is needed to find a large number of substances with 
different physical/chemical properties.  GC-MS, HPLC with Diode Array Detection (DAD) 
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and immunological screening methods are combined to minimize the chance of false 
negative or positive samples.  
Great handicaps for analysis are the different kinds of organic matrices. Neat spiked 
solutions as well as nearly matrix-free samples, such as tablets, are relatively simply 
analyzed and results generally are satisfactory (Oberacher, Pavlic et al. 2009; Pavlic, 
Schubert et al. 2010). However, the effect of matrix components on the analysis is 
unpredictable. Depending very much on the sample preparation process, some 
unknown biological compounds may not be removed sufficiently and thus interfere with 
the ionization of the analytes. In LC-MS, the signal can be suppressed or enhanced, thus 
possibly leading to false results, analytes at low concentrations could be missed. 
Moreover, additives or solvent residues can interfere. 
The aim of this work was to evaluate the features and limits of toxicological MS analysis 
using a certain linear ion trap, the LTQ Velos (Thermo Fisher Scientific). Thus, the ideal 
settings for specific analytical questions were determined, while also considering HPLC 
influence. This work purely focuses on the possibilities for qualitative screening with the 
LTQ Velos mass spectrometer. Identification is the prerequisite for quantitative 
determination. Although it can be important to know the exact amount of an identified 
toxin (e.g. for determination of the cause of death), the methodical and instrumental 
requirements for quantitative analysis would differ greatly and were not addressed in 
this work.  
 
2.1 Background 
 
A number of different methods are commonly used for Systematic Toxicological 
Analysis. GC-MS is currently the “gold-standard” for most analytical questions; other 
methods commonly used are LC with DAD and immunological screening procedures. 
Although neither method is sufficient by itself, they complement each other well for a 
profound toxicological screening. 
GC-MS utilizes very large existing libraries (e.g. “NIST MS 11”, currently 243,893 spectra 
of 212,961 compounds, on September 8th, 2011) and well established reliable methods. 
GC offers a high resolution power. Electron Impact (EI) ionization is highly reproducible 
through all instruments. EI triggers dissociation during ionization, no further collision 
step is required. EI is classified as “hard ionization method”, thus generating a higher 
amount of fragmentation, hence yielding more information. MS detectors work only 
under high vacuum, making GC a suitable separation technique. However, this 
advantage is also the method’s major drawback. Chromatography is performed in the 
gas phase, thus excluding non volatile or thermo labile compounds for direct analysis. 
Although derivatisation enlarges the amount of substances detectable, it makes time 
consuming sample preparation necessary. Although GC-MS is the gold-standard for STA, 
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development of routine LC-MS methods is progressing very fast, continuously gaining 
significance. 
DAD as detector for LC is much less specific than MS. Identification can only be done by 
Retention Time (RT) and a corresponding reference UV/VIS spectrum. Moreover, the 
appearance of an optical spectrum can be strongly influenced by a number of 
parameters, such as the solvent, the pH and possible coeluents. Optical spectra yield 
much less information (e.g. structural) and are only available, when the molecule 
contains a chromophore. However, there are fewer problems with transferability of 
spectra, large libraries exist and liquid samples do not have to be transferred into gas 
phase/vacuum. Also, the technical complexity is much less than for mass detectors, with 
therefore increased cost effectiveness. 
Immunological screening systems range from the quick and easy to use “on-site tests” 
to complex methods which require laboratory facilities and trained personnel. Usually 
predefined compounds are detected via reaction with specific antibodies. 
Unfortunately, this reaction is seldom absolutely specific. Depending on the method, 
false positive results due to cross-reactions can easily occur and tests are only available 
for a relatively small number of defined substances. The use of this method for quick 
testing especially outside laboratories is undisputed, as it can also be performed by 
untrained staff. However, no “STA” can be performed as these methods are always 
targeted on a limited number of substances. Furthermore, each substance or substance 
class requires a unique immunological method. 
Next to these commonly used methods of GC-MS, LC-DAD and Immunological 
screening, LC-MS as method for GUS has been developed and routinely used since more 
than a decade. Coupling LC to MS was made possible through the development of new 
interfaces and Atmospheric Pressure Ionization (API) methods such as Electrospray 
Ionization (ESI) and Atmospheric Pressure Chemical Ionization (APCI). The need for 
these developments evolved from the problematic transfer of liquid into gas phase, 
especially at high liquid flow rates. At present, the combination of Liquid 
Chromatography and Mass Spectrometry is a widely used technique in many different 
fields of science. From big and very complex bio-molecules analyzed in proteomics to 
small-molecules analysis in toxicology, all fields are represented. A broad range of 
adapted instruments and methods are available for different applications. LC-MS is 
already being routinely used in clinical and forensic laboratories; however method 
development is still an ongoing process. 
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2.2 Approaches to Toxicological Screening 
 
2.2.1 General Principles 
The great range of available Mass Spectrometers makes many different screening 
approaches possible. Their common aim is to detect and identify relevant ions out of 
the vast amount of endogenous and exogenous components. Both clinical and forensic 
toxicologists have a high need for profound screening methods; the substances 
screened for are often similar. Methods should be validated, according to current 
guidelines (e.g. the International Conference on Harmonisation (ICH) or European 
Medicines Agency (EMA)), as the results have to be very reliable because of their 
serious medical or legal consequences.   
Depending on the many different objects of screening, different principles have been 
observed. The problems of screening in matrix require more sophisticated methods 
than the analysis of simple tablet or powder samples. Post mortem brain samples have 
to be prepared in other ways than urine. Methods in clinical toxicology have to be very 
fast whereas forensic toxicology methods have to be very reliable. Living patients can 
offer additional information, whilst there might be no a priori information about the 
cause of death in a forensic case. In general, STA can be needed in clinical as well as 
forensic toxicology. The sample matrix can vary, as can the concentrations and specific 
requirements, but the general methods are the same. 
Some common principles apply for screening on many different types of instruments. 
Methods can be classified as ‘targeted’ or ‘non-targeted’. Targeted screening implies 
the search for predefined substances. This pre-selection is usually correlating with a MS 
library. Hence, the more entries there are in the library, the more profound the search. 
A very high number of toxins are known substances, e.g. prescription drugs, which can 
be easily added to a library by infusing neat standard solutions. The structures of new 
‘designer drugs’ or many metabolites on the other hand, are often unknown and 
therefore not included in libraries. This is the main disadvantage of any targeted 
screening – no entry in the library means wrong results. The quality of the search is 
therefore highly dependent upon the quality of the library, the search algorithm and 
additional exclusion criteria. The quality of the reference spectra is another factor 
influencing search results. A number of methods have been developed for only a limited 
number or certain classes of substances (Nielsen, Johansen et al. 2010). The risk of false 
negative and positive hits is low; however it increases with the number of entries in the 
library. This cannot be compared to STA procedures and libraries with e.g. over 1500 
entries where the chance of similar spectra is much higher. To eliminate false positives, 
search criteria have to be very strict, concerning deviation of RT and recorded mass 
spectrum. At the same time the search criteria must not be a reason for possible false 
negative results. Methods operating with larger libraries have been published, but only 
investigated urine or non-biological matrices (Pavlic, Schubert et al. 2010; Mueller, 
Duretz et al. 2011).  
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Targeted screening can either be performed in full scan mode with DDA or as SIM 
(Selected Ion Monitoring) or SRM/MRM (Selected Reaction Monitoring, Multiple 
Reaction Monitoring). Full scan spectra a usually yield the most information, SIM the 
least. SIM only monitors a single mass, without any fragments. This can be used for 
quantification of a known component or for screening with high resolution instruments, 
such as Time-of-Flight (TOF) detectors. SRM/MRM monitors the transition of a 
precursor ion into one or more specified product ions. Additional data is hereby 
obtained from the relative mass intensities and the retention time in the 
chromatogram. A full scan can be used for the initial survey scan and the following data-
dependent product ion scan. This spectrum shows all produced product ions, including 
their intensities. The most commonly used method for fragmentation with LC-MS-MS 
instruments is Collision Induced Dissociation (CID). It can be performed in a quadrupole 
or an ion trap collision cell. However the spectra produced with either method are 
difficult to compare, as will be explained below (2.2.2). 
The European Union Commission (Communites 2002) states that, for comparison to 
validated reference spectra, at least 4 ions should be present with at least 10% 
abundance of base peak for full scan spectra. For SIM/SRM/MRM experiments, the 
commission assigns Identification Points (IP), depending on the used method and the 
number of given ions. For example, LC-MS² with one precursor and two product ions 
would gain 4 IP (1 + 1.5 + 1.5 = 4); Minimum number of required IP is 4. Relative 
abundances also have to be taken into consideration, given limits have to be met. In 
general, full scan spectra or Enhanced Product Ion (EPI) spectra provide more reliable 
identification. High resolution data is awarded one additional IP for each ion (e.g. 2 
instead of 1 for matching precursor). 
Another option is performing a non-targeted GUS via intensities. (Wissenbach, Meyer et 
al. 2011) Hereby, no substances are predefined; the selection of precursor ions is based 
solely on their abundance. From one full scan, e.g. the 5 most abundant ions are 
selected for fragmentation. This minimizes the problem of pre-selection but becomes 
very difficult if real samples containing matrix are analyzed. Even the most thorough 
sample clean up cannot exclude all matrix in advance, especially without also excluding 
possible analytes. Besides, a toxin could be present at very low concentrations and 
would therefore not be selected for fragmentation. Matrix components with very high 
abundance can conceal other components. Known interferences might be put on a 
“reject” list and excluded from analysis beforehand, but there is still a chance for 
relevant components having identical m/z. Very strict “dynamic exclusion” settings can 
here be of considerable use. Success is also strongly dependent upon the separation 
power of the chromatography and the shape of the peaks.  
A possible approach could be the combination of targeted and non-targeted screening. 
Ions on a list should be recorded, even when present at low concentrations. 
Additionally, high abundant ions not included on the list should be chosen too. 
Wissenbach et al. (Wissenbach, Meyer et al. 2011) uses multiple metabolites for the 
identification of one single compound. Of the many metabolites present in urine 
derived from one drug, not all might be identified. However, a sufficient number will be. 
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This is a rather robust method and additionally confirms body passage. Unfortunately, 
the method was exclusively designed for 45 antidepressants; already over 500 identified 
metabolite spectra were included in the search. For STA and a great range of possible 
analytes, the limits of this method are soon reached.  
For targeted and non-targeted screening alike the selection of the highest screening 
order applied is a delicate task. It is possible to produce solely MS² or MS³ spectra for 
comparison with a library, or a combination of both. Spectra in MS² often yield only 
little information (e.g. one single fragment), or two different structures may even show 
a very similar fragmentation pattern (e.g. derivates). Two ions with identical m/z could 
be present, resulting in a mixed spectrum. Here, MS³ can be an advantage. On the other 
hand does applying MS² and MS³ to every precursor ion result in fewer full scan to full 
scan cycles over time. This might even double the full scan to full scan cycle time, 
depending on the exact setup of the method. In general, MS² is mostly sufficient, in 
some cases even the highest order possible, however MS³ can be an enhancement in 
information.  A pragmatic approach might be the application of MS³ only when 
necessary, e.g. through a predefined list, if the used software permits this sort of 
strategy.  
For all strategies, ionization of substances in positive or negative mode has to be 
considered. The majority of toxicological relevant substances contains nitrogen and/or 
is basic, therefore ionizes in positive mode. Molecules with acidic functional groups 
generally also ionize well in negative mode. Newer MS instruments can rapidly switch 
between positive and negative scan mode, allowing detection of basic and acidic 
compounds in one run. The number of scans per cycle appointed to negative or positive 
mode should be chosen accordingly. Some strategies however, focus purely on basic 
compounds (Köhler, Grobosch et al. 2011). Using two separate ways of sample 
preparation is another possible approach (Stimpfl 2011). The extraction is specific for 
acidic/neutral and basic compounds, followed by two separate analytical runs.  
 
2.2.2 Instrumental Strategies for Mass Spectrometry in Toxicology 
Today’s possibilities have strongly advanced since the first LC-MS attempts. Early 
strategies involved simple single MS or triple quadrupole instruments. Today, a Full 
Scan or MRM followed by a Data Dependent Acquisition (DDA) triggered full Product 
Ion (PI) scan, is the state of the art (Moffat, Osselton et al. 2004).  Full scan mode leaves 
room for retrospective, untargeted, manual review whereas MRM is strictly confined to 
preselected targets. DDA can be either targeted or, based on intensities, untargeted. 
Even a mix of both is possible if MS² and MS³ experiments can be combined.  
Different strategies for MS are applied in Toxicology, with different aim and emphasis. 
In a quick overview, five different instrumental strategies will be introduced: The early 
stages of LC-MS screening were performed with ‘in-source‘ CID on single-stage MS. 
Extensive research was put into development of reproducible spectra. Triple 
quadrupoles (QqQ), which are clearly the method of choice for quantification where 
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also assessed for qualitative screening. More profound information was gained when 
hybrid instruments such as quadrupoles with Linear Ion Traps (QqLIT) were used. 
Simultaneously, genuine ion traps were developed. High resolution Instruments, such as 
TOF detectors and especially the QqTOF hybrids are the most sophisticated instruments 
used for screening today. 
For all LC-MS methods, two main sources of ionization are commonly used. The 
instrumentation requires API methods; ESI and APCI are equally popular. APCI can be 
used with a higher liquid flow and is less susceptible to ion suppression effects (Mueller, 
Duretz et al. 2011); On the other hand in-source fragments can be produced 
accidentally which might possibly conceal the molecular ion (Wissenbach, Meyer et al. 
2011). Molecules can be fragmented after ionization. This takes place either right away 
at the source while entering by collision with the orifice (“in-source CID”) or in a 
“collision cell” after the first Q-stage. However, in-source CID shows major drawbacks 
and is only necessary if no such cell is present (e.g. with single MS instruments). As 
collision cell, the second of three quadrupoles, Qq-hybrid instruments or simple ion 
traps can be used. The cell is filled with gas, e.g. nitrogen, helium or argon. Depending 
on the gas pressure, the amount of ions in the cell and the applied collision energy, the 
fragmentation can be regulated.  
In source CID, mostly used with single MS, is strongly dependent upon the design of the 
instrument, the shape of the orifice and the placement in the source. Fragmentation 
can be influenced by variation of the cone voltage only. Sufficient reproducible spectra 
are only obtained with instruments of the same “family” from one manufacturer 
(Bristow, Nichols et al. 2002). Especially between instruments of different 
manufacturers the spectra do not only vary in the abundance of ions but also in spectral 
content. Two main strategies for increasing the reproducibility where assessed by 
Bristow et al., a tune compound protocol at low and medium Collision Energy (CE) and a 
[M+H]⁺ ion attenuation protocol. The tune compounds where used to establish ideal 
conditions at two different collision energies. As this approach did not sufficiently work, 
the [M+H]⁺ ion attenuation protocol was developed, whereby the extent of 
fragmentation is chosen so that the molecular ion is reduced to 50% of its original 
abundance. Both methods were supposed to adapt one instrument to the settings of 
another. It was found that neither approach would be sufficiently transferable to all 
other instruments.  
Venisse et al. (Venisse, Marquet et al. 2003) states that only with in-source CID a 
complete GUS is possible because no ions are primarily excluded. They created their 
own library with reconstructed spectra from two different collision energies (±20V and 
±80V) for routine application. A big emphasis for single-MS is on the chromatography 
because the noise reduces sensitivity greatly. Venisse et al. used enhanced data 
processing (for chromatography and spectra) to improve the signal/noise ratio. A 50 
min gradient was used to reduce co-elution. Today, other methods are available to 
avoid pre-selection of ions. However it should considered that one can only identify 
what is already known, if no reference is available, no identification is possible. 
Moreover, the runtime of 50 min is another major drawback, as the time saving 
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advantage in comparison to GC is lost. Today, in-source CID is obsolete for single stage 
MS. However for single TOF instruments, in-source CID can still be a useful additive. The 
abundance of fragments and even the content of the spectrum have less relevance 
because the exact mass of all fragments is measured. 
Nowadays, the strategies to systematic toxicological analysis mostly include Tandem-
MS or high resolution detection. QqQ, QqLIT, simple traps, LIT or TOF detectors are 
available from different manufactures, with many available features.  
QqQ instruments have a very high selectivity and also sensitivity, ideal for working with 
preselected ions. Their use for quantification is undisputed; however the possibility of 
screening is limited, due to the low sensitivity in this mode. To perform a SRM followed 
by an EPI scan needed for a comprehensive toxicological screening, two injections of 
the sample are necessary. Although 4 IPs would be sufficient for identification (one 
precursor ion and two product ions, 1+1.5+1.5=4) it may be doubted whether this really 
is a sensible STA screening. Limited speed and capacity might be another drawback for 
the application of this method in analytical toxicology. QqQ can be used for additional 
confirmation of substances identified in screening, and especially for their 
quantification.  
QqLinear Ion Trap (QqLIT) instruments can be utilized in QqQ mode or with the third 
quadrupole working as a LIT. This allows collecting ions prior to detection in order to 
receive a full product ion scan after dissociation. Firstly, a MRM experiment is run to 
screen for a number of possible, preselected precursor ions and their most significant, 
also preselected, product ion. Secondly, after CID takes place in the second quadrupole, 
a full scan of the fragments is triggered via DDA. In general, one normalized CE is 
applied, regulated through the gas pressure and the applied voltage. All ions present in 
the quadrupole are activated and can possibly fragment. The pseudo-molecular ion is 
activated and dissociates into fragments which themselves are activated again. This 
process is repeated continuously, as long as the activation is performed, and 
fragmentation is therefore a cascading process. This is the major difference to 3D Ion 
Traps, as explained below.  
A number of recently published strategies use the “QTrap” (ABSciex), a QqLIT (Mueller, 
Weinmann et al. 2005; Dresen, Ferreiros et al. 2010). To enhance the simple MRM/EPI 
scan methods, Dresen et al. introduced the scheduled MRM (sMRM) scan, which only 
screens for certain analytes within a specified timeframe, therefore allowing more 
analytes to be included in the search and minimizing interferences. They also performed 
semiquantitative analysis with the hybrid LIT; using deuterated standards to minimize 
the effects of fill time and matrix. However they cannot quantify as reliably as QqQ 
instruments, because the trap fill time greatly influences the measurement. Detection 
in traps is not performed continuously but rather dependent upon the amount of ions 
present in the trap. This is important for having a stable signal if only few ions are 
present and to avoid overloading the trap if a great amount is available.  
Genuine Ion Traps can have a linear or 3D construction, where CID and detection scans 
are performed in the same space. Hence, the detection has to be performed in a gas 
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filled cell, therefore reducing sensitivity in detection. Prior to CID, ions of a selected m/z 
are isolated in the trap and activation is directed specifically. This increases the 
signal/noise ratio and, furthermore, it is the reason why spectra produced in 
quadrupole collision cells cannot be compared to spectra from an ion trap. No further 
cascading fragmentation process takes place. CID in traps often produces very few 
significant fragments, one of them typically being the “waterloss peak”. The waterloss 
fragment occurs when the molecular ion is activated and dissociates into [M – H₂O] ⁺ 
which is generally very stable and does not fragment further. New technical 
developments such as “Wideband”, “Stepped Collision Energy” (Thermo Fisher 
Scientific) or “Collision Energy Spread” (AB Sciex) can spread the activating energy over 
a broad range, thus fragmenting the waterloss peak and therefore yielding more 
information. These features will be discussed in the Material and Methods section 
(3.2.1). 
Mueller et al. and Sturm et al. (Mueller, Weinmann et al. 2005; Sturm, Hammann et al. 
2010) developed multi-target screening methods on LXQ and LCQ ion traps from 
Thermo Fisher Scientific. The general method is created with the Xcalibur software for 
both Instruments and is also comparable with the general method creation for the LTQ 
Velos. 
The LTQ Velos used for this work is a further development of the basic ion traps. It is a 
LIT with one high and one low pressure cell, realizing a tandem-in-time rather than the 
tandem-in-space concept of QqLITs. The survey scan, the CID (with helium gas) and the 
product ion scan (after DDA with a certain threshold), are performed in two separate 
regions. In the low pressure region, detection is much more sensitive than in common 
traps, as no collision gas is present. No compromise has to be made and very fast 
switching from positive to negative mode in one cycle can make the information 
acquisition even more thorough. No GUS procedure performed on a LTQ Velos has yet 
been published. When connected to an “Orbitrap” (Thermo Fisher Scientific), the Velos 
can even produce additional high resolution information. Produced data would 
repeatedly be verified. The RT, molecular mass, MS² and/or MS³ spectrum and exact 
mass measurement mutually confirm results. 
TOF instruments combine accurate mass measurement with RT for identification. 
Unless in-source CID is applied, no deliberate fragmentation takes place. Although very 
much information can be gained through high resolution data, some issues cannot be 
resolved. One exact mass applies to all molecules of equal chemical formula. This 
includes structural isomers as well as random matches. However, data can also be 
reviewed retrospectively, because without pre-selection of ions, all peaks above a 
certain threshold are recorded. 
Nielsen et al. (Nielsen, Johansen et al. 2010) developed a method for 52 substances in 
hair. They state that the selectivity of the method is equal to methods monitoring ion 
transitions and their relative ratios with MRM. As mentioned above, all single MS 
methods are very susceptible to interferences with matrix components or solvent 
residues. A big emphasis has to be put on the chromatography, which takes only 17 
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minutes for the described method.  They were even able to partly quantify in the same 
run as the screening. This is actually not recommended by the TIAFT as they suggest 
that “Quantitation should ideally be performed on an aliquot of the sample other than 
that used for screening and/or qualitative analysis.” (http://www.tiaft.org/node/82, 
11.9.2011). Libraries for high resolution data can even be created from theoretical 
masses, possibly supplemented with spectral data.  
High Resolution Hybrid Instruments (e.g. QqTOF or LIT-Orbitrap) have the big 
advantage of measuring the accurate mass in combination with fragmentation data. 
Both MRM and full scan screening are possible. Spectra created in a non-targeted 
screening (e.g. via intensities) can lead to identification of primarily unknown 
compounds, e.g. metabolites.  
Broecker et al. (Broecker, Herre et al. 2011) developed a method for LC-QTOF-MS with 
DDA for more than 2500 substances. Spectra were taken after CID at 10, 20 and 40eV. 
The reconstructed spectra were checked for plausibility and adjusted according to their 
calculated exact mass. Again, retrospective analysis can be an advantage.  
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3 Material and Methods 
 
3.1 Chemicals and Reagents 
3.1.1 Internal Standard Solution 
Three deuterated standards (morphine-d₃, benzoylecgonine-d₃ (BZE), and methadone-
d₃) were purchased from Sigma-Aldrich Co. (USA), and solutions with 12 neat standards 
in three different concentrations (1 and 10mg/ml) in methanol were available from 
previous extractions. Diluted stock solutions of 10 µg/ml in 50% MeOH - acetonitrile 
(ACN) (1+1) with 0,1% glacial acetic acid were used to create library spectra. 
For ensuring the reproducibility of the HPLC System a mix of the three deuterated 
standards was prepared (“Internal Standard Mix”). The substances were chosen to 
cover the standard 10 minute gradient run. Morphine-d₃ elutes at 0,84, BZE-d₃ at 4,07 
and methadone-d₃ at 6,78 minutes, respectively. 
The internal standards mix was used to evaluate retention times. Therefore, two 
different approaches were examined. Firstly, three MS² scans on the precursor masses 
were run permanently (Fig.1). Secondly, a DDA method was applied which only triggers 
a MS² scan if one of the three precursor masses appears with an intensity of over 100 
counts in the full scan (Fig.2). The peaks were well visible in both Total Ion 
Chromatograms (TIC), though the first approach showed a better peak performance, 
allowing easier determination of the exact retention time.  
 
 
Fig. 1: Internal Standards Solution; screening with three MS² scans 
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Fig. 2: Internal Standards Solution; screening with DDA 
 
3.1.2 Testmix 
A mixture of 13 substances, (from the 12 standard solutions plus one deuterated 
standard) as listed below (recommended in Toxichem Krimtech 2011; 78(1)-65), was 
prepared. These substances have different physical and chemical characteristics, chosen 
to cover different analytical problems. They have basic and/or acidic functional groups - 
to include positive and negative ionization, and different polarities to cover the whole 
chromatographic range. BZE-d₃ was used to differentiate between a product of 
degradation (of cocaine) and the added standard. All substances, their concentrations, 
precursor ions and the established RTs are listed in Tab. 1. THC refers to the delta-9-
tetrahydrocannabinol and THCA to the 11-nor-9-Carboxy-THC. The Testmix was used to 
evaluate the prospective methods for screening and corresponding settings.  
 
Substance Concentration 
µg/ml 
Relative RT (min) 
(12 min run) 
m/z +H 
Amphetamine 50 1,75 136 
Benzoylecgonine-d₃ 50 4,04 293,3 
Cocaine 50 5,56 304,1 
Codeine 50 1,89 300 
Diazepam 50 6,32 285 
Doxepine 50 6,35 280 
Ibuprofen 500 6,49 207 
Methadone 50 6,75 310 
Metoprolol 50 5,16 286 
Morphine 50 0,84 286 
Phenobarbital 500 4,44 231 (-H) 
THC 5 7,56 315 
THCA 5 7,05 343 (-H) 
Tab. 1: Testmix components used for the Experiments 
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3.2 Apparatus and Software 
3.2.1 Mass Spectrometry 
For the MS analysis a LIT (LTQ Velos, by Thermo Fisher Scientific, USA) was used. The 
novelty of this instrument in comparison to other, commonly used LITs are its two 
separated trap regions (Fig. 3). Inside the high-pressure cell the CID takes place, while 
detection happens in the low-pressure cell. The high vacuum makes the detection more 
precise. The LTQ Velos therefore realizes a tandem-in-time concept rather than a 
tandem-in-space concept applied by common hybrid systems.   
 
Fig. 3: LTQ Velos, Thermo Fisher Scientific 
For ionization two different ESI source settings and one heated ESI (HESI) where 
applied. When combined with HPLC, ESI source settings had to be adapted to fully 
evaporate the solvent flow rate of 0,3 ml/min (Tab. 2). 
Additional heating of the gas (HESI) implies less thermic stress on the molecules 
because the MS entrance capillary temperature can be set much lower. This approach 
was consequently applied. 
Setting Direct Inf.  HPLC HESI 
Sheath Gas Flow rate (arb) 8 35 25 
Aux Gas Flow rate (arb) 0 10 5 
Sweep gas Flow rate (arb) 0 0 0 
Spray Voltage (kV)(+/-) 5 3 3/2,5 
Source Heater Temp. (°C) 0 0 300 
Capillary Temp (°C) 275 350 275 
Tab. 2: ESI-Source Settings; for direct infusion (5-15µl/min), with HPLC and HESI (300µl/min) 
 
Special features are the “Normalized” and “Stepped” Collision Energy (NCE, SCE) as well 
as the activation of Wideband. NCE allows a comparison of spectra taken on different 
instruments. The amount of collision energy (CE) applied varies according to the size of 
the molecules. Big molecules need more energy for the same degree of fragmentation 
than small molecules (Fig. 4). Thus the energy is not specified as eV but rather as 
percentage.  
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Fig. 4: Optimum CE for differently sized molecules (Thermo Fisher Scientific) 
SCE means the application of more than one CE. This ensures complete fragmentation 
of molecular ions. No additional spectra are created and superimposed upon one 
another but the original is complemented by additional information. Steps can vary in 
size and number. For example, 20% SCE with 3 steps would result in the addition of -10, 
0 and +10% to the NCE base value. At 40% NCE with SCE enabled, the precursor ions are 
fragmented with 30, 40 and 50% NCE, respectively. 
Activation of the Wideband feature can advance the content of the spectra. Instead of 
generating only one significant fragment through the dissociation of water, the 
activation is performed over a larger range, after the isolation is performed on a rather 
small window. Hence, the waterloss peak is also activated and further fragmentation 
leads to more information in the spectrum (Fig. 5)  
 
Fig. 5: Wideband Activation (Thermo Fisher Scientific) 
 
Calibration and Tuning were performed according to the recommendations of the 
manufacturer of the instrument, using a mixture of 50% MeOH - ACN (1+1) with 0,1% 
glacial acetic acid; Calibration components were: caffeine, MRFA (L-methionyl-arginyl-
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phenylalanin-alanine acetat *H₂0, MW: 523,7), Ultramark 1621 (a mixture of fluorinated 
phosphazines) and n-butylamine.  
Calibration was performed with each of the three prospective source settings, 
depending on the requirements of the proximate experiments. Tuning was usually 
performed immediately after calibration with the internal standard mix. Tuning was 
performed according the system (small molecules) which was subsequently used. 
Calibration is a source dependent procedure while tuning is dependent upon the 
analytes. 
Calibration was continuously verified and performed weekly.  
 
3.2.2 Software 
Xcalibur (Version: 2.1) from Thermo Fisher Scientific was used to operate the LTQ Velos 
and for collection of data in the raw files. Chromeleon 6.8 (Dionex) was used for the 
HPLC. Both ToxID (Version: 2.1.1, Thermo Fisher Scientific) and SmileMS (Version: 1.2.3, 
Genebio) were used for data processing.  
The library included (Tox_Library) was initially used and complemented with new 
spectra and additional information. Originally, 329 MS² spectra are included. No MS³ 
spectra and no information about the chemical formula, structure, CAS number or 
synonyms are provided and had to be supplemented. 
 
3.2.3 Xcalibur Methods 
3.2.3.1 Methods for Direct Infusion 
Neat standard solutions, the internal standards mix and the Testmix were directly 
infused for the creation of library spectra, as well as examining the effects of different 
parameters (such as NCE, SCE, Wideband activation, activation time, influence of 
solvent composition…).  
3.2.3.1.1 Single Substance Methods 
All methods were specifically programmed with the Xcalibur Software and adapted for 
each purpose. A runtime of typically five minutes guaranteed a stable ion spray and 
reproducible data. The number of scans per cycle was chosen individually for each 
experiment and either data dependent or for a preselected precursor ion. The following 
parameters were tested to enhance the information content of spectra: activation of 
wideband, stepped collision energy and different NCEs, as well as additional microscans 
and activation time (Tab. 3).  
20 
 
 
Tested Feature Tested Settings Optimum Setting 
Normalized Collision 
Energy 
20, 35, 40, 60 and 200% 40% 
Wideband Off/On On 
Additional Microscans 1/2/3/4 Dep. on MS Order 
Stepped Coll. E Off/On  On, with 20%, 3steps 
Activation Time 10,30, 50 and 100 ms 30 ms 
Tab. 3: Tested scan features 
The infusion was performed at 5µl/min (with a Hamilton Syringe, 500µl) with the ESI 
source settings described above.  
The default method, developed with the optimum setting of instrument features and 
parameters,  used for library spectra creation consists of a full scan and specific MS² on 
the known precursor ion with 40% NCE, 20% Stepped CE (3 steps) and 30ms activation 
time. The full scan was performed to confirm the presence of the precursor ion and its 
overall abundance.   
A selection of all used methods is listed in the appendix (App. 13) and discussed in the 
results (4.2).  
3.2.3.1.2 Substance Mix Methods 
Four different methods were developed to test initial settings of the LTQ Velos on the 
Testmix, without HPLC. All methods had the same sequential setup. After a full scan in 
the positive mode, DDA triggers MS² scans on the most intense ions from a precursor 
mass list (called “parent mass list” in Xcalibur). If no ion from that list is detected, no 
scan will be triggered. Afterwards a full scan in negative mode followed by DDA MS² 
scans is performed. The list includes m/z of ions within a RT frame to select for 
fragmentation. Additionally, a specific NCE can be assigned to each m/z and ions can be 
selected for MS³. It should be mentioned that only ions included in the list can be 
selected, unless the option “most intense if no parent mass found” is applied; hence the 
methods are targeted.  There are always more scans in positive mode than in negative 
because about 80% of all drugs are basic, hence ionize in positive mode (addition of H⁺).  
  
21 
 
Full scan,  
negative  
MS2 MS2 
Methods in detail:  
 
Method A (Fig. 6) is built up of 14 scans. One full scan in positive mode is followed by 10 
positive DDA scans (MS²).The 12th scan is a full scan in negative mode, followed by two  
negative DDA scans.  
 
Fig. 6: Method A 
    
 
 
Method B (Fig.7) is built up of six Scans in total. One full positive is followed by three 
positive DDA scans. The 5th is a full scan in negative and the 6th a negative DDA scan. 
    
 
Fig. 7: Method B 
 
Method C1 and C2 (Fig.8) are based on the method recommended by Thermo Fisher for 
STA and slightly adapted by one additional negative scan. They consist of 9 scan events 
in total with one full positive, five DDA positive, one full negative and two DDA negative 
scans. This method was also amplified by a special parent list. The so-called “128-500” 
parent mass list contains all m/z from 128 - 500 (including all mass from the library), 
hence simulating a real GUS. 
Full Scan, 
 positive 
MS2 MS2 MS2 MS2 MS2 MS2 MS2 MS2 MS2 MS2 
Full scan, 
positive 
MS2 MS2 MS2 
Full scan, 
negative 
MS2 
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Fig. 8: Method C1 and C2; default for most experiments 
The difference between C1 and C2 is the application of Dynamic Exclusion (DE) in C2, as 
stated in Tab. 4.  
 
Repeat count 2 
Repeat duration 10,0 sec 
Exclusion list size 25 
Exclusion duration 60 sec  
Tab. 4: DE settings for method C2, direct infusion 
The repeat count specifies the number of scans performed on a certain m/z, needed in 
a certain time frame (repeat duration) to trigger dynamic exclusion. The specific m/z 
will then be put on the exclusion list for a certain amount of time (exclusion duration). 
The exclusion list can be limited to a certain number of substances. If this number is 
exceeded, the earliest entry is removed to make room for new precursor masses.  
 
3.2.3.2 HPLC – MS Methods 
As detection of ions shows little success without prior separation through 
chromatography, specific methods for HPLC-MS screening were developed. Both the 
Testmix and the internal standards mix were used, as well as single substances for 
specific questions. Considering the approaches of Thermo Fisher for ToxID (Rezai, Kozak 
et al. 2007) for a default method for STA and Mueller et.al (Mueller, Duretz et al. 2011) 
concerning MS² and MS³ combined screening, Method C1 and C2 were applied and 
developed further. Additionally, the “nth Order Double Play” approach was tested. 
Special methods were created to determine the RT of the internal standards (3.1.1). 
The samples were injected at a mobile phase flow of 0,3ml/min with 2µl injection 
volume. The solutions and the HPLC gradient system were prepared and run as 
described below.  
The “nth Order Double Play” method (Fig. 9) is another approach to screening with 
Xcalibur. This method facilitates a much higher scan rate. However, only either positive 
or negative mode is available within one run. The original method consists of only two 
scans within one segment. The first is a regular full scan while the second is a DDA scan 
Full scan, 
positive  
MS2 MS2 MS2 MS2 MS2 
Full scan, 
negative 
MS2  MS2  
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which can be repeated for up to 10 times. As these 10 scans are referred to as one scan, 
they cannot be modified individually.  
 
Fig. 9: The "nth Order Double Play" approach 
 
Moreover, three different approaches to screen samples with additional MS³ are 
available within Xcalibur. One was also applied by Mueller et al. (Mueller, Duretz et al. 
2011) and another by Wissenbach et al. (Wissenbach, Meyer et al. 2011). 
First, the concept of scans (Methods A, B and C) can be adapted to accommodate MS³ 
for each MS² scan (Fig 10). 
 
Fig. 10: Method A, adapted for MS²+MS³ 
 There are two ways of determining which ion from the MS² scan is selected for MS³. 
 The “most intense” ion  
 The “most intense ion from the list”  
To choose the “most intense ion” means to collect MS³ data for every MS² scan, 
whereas the “most intense ion from the list” option only optionally triggers a scan. 
The list had to be expanded by the MS³ precursor ions, hence a combined MS² and MS³ 
parent mass list was used. 
These two approaches could be taken further to accommodate MS³, MS⁴ or even higher 
order scans. 
Full scan, 
positive  
DDA-MS2 
1 2 3 4 x 
Full scan, 
positive 
MS2 
MS3 
MS2 
MS3 
MS2 
MS3 
MS2 
MS3 
Full scan, 
negative 
MS2 
MS3 
MS2 
MS3 
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As a third approach, a certain fragment (produced in the MS² scan) was assigned to the 
substances on the parent mass list, and individual collision energy. Xcalibur then 
triggers the consecutive MS³ scan automatically, if the parent mass is chosen for MS². 
This is possible up to MS³ only. Individual treatment for certain substances was 
therefore possible, but MS² data was no longer available for selected ions.   
ToxID allows a search for MS², MS³ and combined MS²&MS³ spectra, respectively. 
Unfortunately, ToxID was only able to identify spectra produced with the “most intense 
ion from the list” approach.  
 
3.2.4 Chromatography 
For the High Performance Liquid Chromatography (HPLC) an Ultimate 3000 RS from 
Dionex was used, run by the Chromeleon (6.8) Software. The separation column was a 
Hypersil Gold PFP 50 x 2,1 mm, packed with 3 µm Material (Thermo Fisher Scientific). 
Column oven temperature was set to 35°C. 
A linear binary gradient was used for chromatography: Mobile phase A was water with 
ammonium formiate (10 mMol, pH 3,3) and 0,1% formic acid; mobile phase B was ACN 
with 0,1% formic acid. The chromatography was run over 15 minutes. Beginning with an 
isocratic phase for 0,5 min (5% B), then raising the amount of B to 95% over 5 minutes, 
followed by 3 minutes isocratic elution at 95% B. One minute with 100% B preceded the 
5 minutes equilibration phase (Fig. 11). The flow was set to 0,3ml/min unless otherwise 
stated. Injection volume was 2 µl, column oven temperature 35°C. 
 
Fig. 11: Gradient elution 
 
3.2.4.1 Retention Time Measurement/Stability 
Stability of the retention of substances over time was tested at mobile phase flow of 
0,3ml/min. Tab. 5 shows a selection of representative RT on two different days. An 
extended list of RTs of the Testmix over the whole period of work is given in the 
appendix (App. 14). 
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Datum/min 21.7.11 21.7.11 27.7.11 27.7.11 SD  
Morphine-d₃ 0,84 0,83 0,84 0,88 0,02 
BZE-d₃ 4,07 4,08 4,07 4,01 0,03 
Methadone-d₃ 6,78 6,78 6,74 6,8 0,02 
Tab. 5: Representative selection of RTs of deuterated standards 
 
For testing the stability of RT for all used components, the flow was set to 0,2, 0,4, and 
0,5ml/min additionally to the default flow of 0,3ml/min. The linear gradient was also 
changed from 5 min to 10 and 15 min. In order to predict the occurring shifts of RTs an 
Excel calculation table (trend) was used. The internal standard solution was run with the 
altered settings (e.g. 0,4 instead of 0,3ml/min). The RTs for the testmix were then 
calculated, based on the change in RT of the three standards. This is necessary, because 
the scan as well as the identification of components is dependent upon the correct RT 
(Fig. 12). 
 
Fig. 12: Calculation of RT after shifts; Excel 
 
During the experiments at 0,2ml/min, shifting of some peaks, especially at early RT was 
observed. Since this may have been due to a problem with the mixing chamber, a “Step-
gradient” was run to estimate the delay and accuracy of the mixing of the solvents. 
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3.2.4.2 Step-gradient elution 
To test the formation of the gradient solvent A was Methanol, solvent B Methanol with 
0,1% Acetone. The fraction of Solvent B was raised by 5% every 5 minutes. Detection via 
UV at 280nm and 245nm. Flow rates of 0,2, 0,3, 0,4 and 0,5ml/min were run. The 
mixing chamber contains a volume of 350 µl. 
 
 
3.2.5 Limit of Detection – Pretests 
In order to support future evaluations of the limit of detection, pretests were run at 
different dilutions. The components of the Testmix were originally present at 5µg/ml, 
50µg/ml and 500µg/ml respectively, as mentioned above (3.1.2). The solution was 
diluted 1:10, 1:100 and 1:1000 with 50% MeOH - ACN (1+1) with 0,1% glacial acetic 
acid. Tab.6 shows the concentrations of the dilutions.  
Concentration/Dilution 1:10 1:100 1:1000 
5µg/ml 0,5µg/ml 0,05µg/ml 0,005µg/ml 
50µg/ml 5µg/ml 0,5µg/ml 0,05µg/ml 
500mg/ml 50µg/ml 5µg/ml 0,5µg/ml 
Tab. 6: Concentration of components present in the Testmix and after dilution 
 
The applied method was Method C (4.2.2.3) with standard HPLC conditions. Threshold 
was set to 100 counts, dynamic exclusion was disabled and Automatic Gain Control 
(AGC) was used to predict ion injection time. 
 
Fig. 13:  Step-gradient; red: 0,5; green: 0,4; black: 0,3; blue: 0,2 ml/min 
27 
 
As the injection volume was 2µl, the following concentrations were effectively applied: 
Orig. Concentration/2µl 
of each Dilution 
2µl at 1:10 2µl at 1:100 2 µl at 
1:1000 
5µg/ml 1ng 0,1ng 0,01ng 
50µg/ml 10ng 1ng 0,1ng 
500mg/ml 100ng 10ng 1ng 
Tab. 7: Concentration injected via HPLC (2µl) 
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4 Results and Discussion 
 
4.1 Introduction 
 
Developing an LC-MS procedure for STA on the LTQ Velos MS requires the setup of 
relevant features. These, depending on the requirements indicated by sample origin 
and desired search outcome, include the instrument parameters, the setup of the 
method, the search criteria and the used libraries. Three different settings for the ESI 
Source were tested. Moreover, the influence of activation parameters on the 
information content and reproducibility of spectra was evaluated, for MS² and MS³. 
Also, two ways to program a method for GUS were applied and examined. The used 
software (Xcalibur) was checked for applicability and practicability for the used 
methods. The screening software (ToxID) was primarily applied and eventually replaced 
by a product from a different manufacturer (SmileMS, Genebio). It had more features 
within a simpler setup, more sophisticated search functions and a considerably better 
interface.  
Calibration was performed with the mentioned mix (3.2.1) and tested for stability over 
the whole working period of six months. It should be performed weekly and it should be 
followed by tuning with representative components – in this case with the 3 deuterated 
standards. Tuning should always be performed in analogy to the procedure applied, 
(e.g. high molecular compounds for proteomics and small molecules for toxicology). 
While calibration is a general procedure, tuning is specific.  
Starting with the very basics of the instrument, the ionization and calibration 
procedures, already some influential parameters had to be considered.   
 
4.1.1 MS-Source Settings 
 
Three different MS-source conditions were tested, two with unheated ESI source and 
one with heated ESI (HESI). 
APCI is said to be less prone to ion suppression effects and can handle higher solvent 
flow rates than ESI (Mueller, Duretz et al. 2011). However, APCI is less sensitive and 
tends to form artifacts in-source during ionization. As we were working with low solvent 
flow rates (max. 0,5ml/min) and did not observe relevant ion suppression effects during 
this work, ESI was considered adequate.  
The solvent flow is one issue when considering source settings. Besides of the gas flow, 
the temperature in the source has to be high enough to evaporate all of the solvent. 
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However it should not compromise the stability of the analytes. The initial settings (see 
3.2, ESI - needle temp. 275 ° C) were only used for direct infusion with a Hamilton 
syringe, at 5-15µl/min. To cope with the much higher flow from the HPLC (0,3ml/min), 
these settings had to be adapted. With an ESI needle temperature as high as 350°C, 
destruction of analytes during ionization is possible, however this was not observed 
with our Testmix. A much more gentle approach with the heated ESI source should 
protect thermolabile molecules. Heating the sheath gas, that flows alongside the 
capillary to assist evaporation, had less impact on the molecules than heating the 
needle itself. Therefore, HESI was considered the standard ionization method for future 
methods (Tab. 8). 
The spray voltage of the needle was recommended by the manufacturer with 3 kV 
(positive mode) and 2,5 kV (negative mode) for HESI. Applying 5 kV (pos) and 3 kV (neg) 
instead had little impact on ionization intensity in positive mode, but much more in 
negative: The spray current (µA) rose to a high level of up to 30 µA (default value: < 5 
µA), which resulted in difficulties with calibration. The calibration components caffeine 
and n-butylamine could not be correctly identified because they disappeared among 
this noise. The following spray conditions were ultimately taken as standard for future 
applications, for a solvent flow rate of approx. 300 µl/min. For direct infusion (5-15 
µl/min), the source heater temperature could be turned off.  
Sheath Gas Flow rate (arb) 25 
Aux Gas Flow rate (arb) 5 
Sweep gas Flow rate (arb) 0 
Spray Voltage (kV) +/- 3/2,5 
Source Heater Temp. (°C) 300 
Capillary Temp (°C) 275 
Tab. 8: Default HESI source settings 
 
4.1.2 Scan Features 
 
Producing spectra for a spectral library is a delicate task. Their quality and 
reproducibility influences every future search result. Ion suppressing or enhancing 
effects can influence the content or intensity of mass spectra. These effects especially 
may vary in different matrices. Moreover, biological samples are not homogenous and 
these effects might not be reproducible. To reduce this risk, spectra should be recorded 
under conditions very similar to future sample processing. The full scans in every cycle 
are controlled by the AGC. It ensures the trap is always filled with a sufficient number of 
ions and avoids overloading. AGC cannot be set manually; therefore it is not considered 
an “influenceable parameter”. Full scans can only be enhanced by applying additional 
microscans. However the default value is one, which is sufficient. Fragmentation for the 
DDA screening is initialized through activation in the trap and is therefore influenced by 
all activation parameters. The following parameters were tested (see also Tab.3; 
3.2.3.1.1): NCE including stepped CE, wideband, additional microscans and activation 
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time. Generally applied values, taken from relevant literature (e.g. (Mueller, Duretz et 
al. 2011), are given in Tab.9:  
Tested Features Generally applied Values 
Normalized Collision Energy 30-45 % 
Stepped Collision Energy ± 5-10 % 
Wideband On 
Additional Microscans 1 for full scan, 2-4 for higher order 
Activation Time 10-50 ms 
Tab. 9: Activation parameters: Generally applied values, taken from relevant literature 
Relevant changes in spectra could be obtained by variation of NCE and activation time 
or by applying Wideband, each with different impact. Wideband generally enhances the 
spectrum content greatly by producing more information than just the waterloss peak.  
NCE and activation time do not influence spectral content, but rather alter intensity 
ratios. The generally applied NCE can vary between instruments and is usually between 
30 - 50%. It should be high enough to fragment a precursor ion completely. The 
performed experiments showed that for small molecules in the Velos-Trap it should be 
about 40%, with SCE enabled at 20% with 3 steps. This implies activation at 30, 40 and 
50% respectively, covering the whole range from low to high CE in one spectrum. 
Spectra generated with this CE showed no or little remains of the molecular ion. This 
reduces variability due to CE. 
Activation time also influences the amount of fragmentation of the precursor ion. As 
shown in the Morphine-d₃ spectra given in the appendix (App. 3), the molecular ion is 
still present after fragmentation at 10 ms. In general, spectra taken at 10 ms show more 
variation in intensities and are therefore slightly less stable. At 30 ms the molecular ion 
is usually fully dissociated, spectra are found to be stable and achieve high search index 
values. However, activation time of 50 ms (App. 4) and higher does not enhance the 
spectrum any further and is otherwise rather time consuming. This was also evaluated 
for MS³ experiments, where it showed considerably more impact than with MS². For 
methadone and cocaine, the same response to activation time as for MS² was observed. 
The intensities of the precursor ion varied at 10 ms and were stable from 30 ms on. For 
the components morphine, doxepine and diazepam the MS³ spectra taken at 10 ms 
were significantly unstable. They became reproducible at 30 and 50 ms; however they 
show differences between 30 and 50 ms (e.g. additional peak at m/z 91,1). Both spectra 
could however, be identified on the basis of the library spectrum taken at 30 ms. MS³ 
spectra taken across the peak at 10, 30 and 50ms are given In the appendix (App.6, 7, 
8). Depending on the weight that is put on the intensity relations for comparison with 
libraries, the impact of activation time can vary. 
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The number of microscans should not change the spectrum content but can improve 
statistical certainty of the results. Microscans can be set for full scans and for each order 
separately via the initial scan features or, alternatively, additional microscans can be 
applied for a certain method. However, additional microscans (as well as longer 
activation time) significantly extend the total scantime, which led from a low number of 
approx. 1500 scans/12 min run (30 ms, 4 microscans for MS²) up to approx. 5000 
scans/12 min run (10 ms and 1 microscan for MS²).  Microscans should be chosen by the 
principle “as much as necessary, as few as possible”. Therefore, one microscan can be 
considered enough for all full scans and 2 - 3 for MS² and MS³ respectively.  
In summary, besides wideband, which changes the content, the greatest impact on 
spectra comes from the activation time. It can alter the degree to which the molecular 
ion is fragmented and is followed by the amount of CE applied. The least influence 
comes from the number of additional microscans. Tested and optimized features and 
settings are listed in the table below (Tab. 10). 
 
Tested Features Tested Settings Optimum Setting 
Normalized Collision Energy 20,35, 40, 60 and 200 % 40 % 
Wideband Off/On On 
Additional Microscans 1/2/3/4 Dep. on MS Order 
Stepped Collision Energy Off/On with 20 %, 3steps On/w 20%, 3 steps 
Activation Time 10, 30, 50 and 100 ms 30 ms 
Tab. 10: Tested and optimized scan features 
The total scantime (resulting from AGC, activation time and microscans) and thus the 
number of scans/run have significant impact on the efficiency of a screening result. To 
increase the number of scans/run while at the same time having reliable identification 
with 30 ms activation time and at least 2-3 microscans for higher order spectra, each 
sample could be analyzed in two separate runs, one in positive and one in negative 
mode. Separate sample workup as described by Stimpfl et.al (Stimpfl 2011) provides a 
good basis for both ionization modes. Additionally, this can help to confirm results as a 
number of ions can be detected in both modes, which would also lead to a higher IP 
score. On the other hand, the LTQ Velos is a very fast and sensitive instrument, 
producing stable scans in positive and negative mode within one run. This is not 
possible in other instruments (e.g. QqTOF) due to their slower work process and 
inability to switch quickly between negative and positive. However, specific preparation 
can also enhance the results, as it would result in a cleaner sample and therefore less 
interference. Moreover, low dose analytes will then more likely be detected. 
Considering all of the above mentioned factors, activation parameters for library 
spectra creation from neat standard solutions on the LTQ Velos should be set as 
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follows: activation time 30ms; NCE: 40%±10% (SCE 20%, 3 steps); microscans according 
to the MS order. Wideband should always be activated. All spectra taken on the 
instrument under these conditions with different DDA methods were sufficiently 
reproducible and identifiable.  
The two spectra of metoprolol given in the appendix (App. 1) show the very high 
resemblance of spectra taken within one run, making the comparison with library 
spectra possible if they are taken under corresponding conditions.  
 
4.1.3. Method Setup 
 
The setup of a MS-method includes the type, amount and order of included scan 
events, the DDA criteria and parent mass list features. The single substance methods 
were used to test individual behavior or to include substances into the library. The 
influence of the amount of scan events was evaluated with four different direct infusion 
methods, A, B, C1 and C2. A selection of all applied methods is given in the appendix 
(App. 13), including internal standard mix, Testmix, single substance and MS³ methods. 
The full 15 minute HPLC run was not always applied – direct infusion methods where 
usually run between 3-5 minutes. This ensured stable spray conditions and a sufficient 
number of reproducible spectra. Methods could be divided into segments, which limit 
certain setups to a specified timeframe. Each segment can accommodate an individual 
amount of scans. Especially direct infusion methods were usually constructed for 
detecting a certain, known m/z. Therefore, no full scan and preceding DDA scans where 
used but rather simple MS²/MS³.  
The number of DDA positive and negative scans after each full scan was varied as 
required.  
The mass range for the detection was set to a default value of 128-827.4, unless 
otherwise stated. This includes all masses on the parent mass list. For MS²/MS³ 
experiments the lower value equals the lower cut-off of the Ion Trap instrument, which 
is about 1/3 of the precursor mass.  
NCE, SCE, activation time and Wideband were varied as required, as well as the parent 
mass list and the DE settings.  
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4.2. Direct Infusion Methods 
 
4.2.1. Specific Methods 
Details for internal standard and single substance methods are given in the appendix 
(App.13). Various methods were used to test single features or to screen for individual 
components. They were applied to estimate RT for the internal standard mix to include 
spectra into the library, for limit of detection pretesting and for MS³ experiments. For 
example, “BZED3_1” was run for five minutes, with four scan events. One full scan was 
followed by three MS² scans (directed to the m/z of benzoylecgonine-d₃; 293,3). The 
scan range was set from 85 to 350. The NCE was set to three different values at 30, 40, 
and 50 %. Activation time was 30 ms, Wideband was enabled as well as SCE. This 
method was used to evaluate the changes in a spectrum at three different CEs if SCE is 
enabled.   
 
4.2.2. Testmix Methods 
The under Material and Methods (3.2.3.1.2) described substance mix methods (Method 
A, B, C1 and C2) were used to test fundamental principles. The indicated full scan to full 
scan cycle time is only approximate, calculated from the average amount of 
scans/minute. In general, full MS scans take less time (about 0,09 - 0,1 sec) than MS² 
scans (about 0,6 - 0,8 sec).   
 
4.2.2.1 Method A (Fig. 6) is built up of 14 scans, which is a high but still realistic 
number of scan events for one cycle. Method A was chosen to show the effect of a 
rather long cycle time in comparison to method B, which has a very low number of 
scans. The average full scan to full scan cycle time is approx. (14 scans x 0,25 seconds) 
3,5 seconds. With one full positive, 10 DDA scans, followed by one full negative and two 
DDA scans. The larger fraction for positive ions is due to the natural distribution of basic 
and acidic drugs, putting more emphasis on the basic compounds. Of the 13 substances 
included in the Testmix screened with method A, 8 were found manually. Two of the 
three negatives were detected. The third one (phenobarbital, m/z 231), which had the 
highest abundance, was not detected, because it was not included in the negative list. 
This had not much influence on the results, as dynamic exclusion was disabled. Would 
m/z 321 have been included, one of the other two (m/z 205 Ibuprofen; m/z 343 THCA) 
would not have been detected instead. Amphetamine (m/z 136) and THC (m/z 315) 
were never selected for fragmentation, due to 1) their low concentration and 2) their 
hence low abundant signals. With DE enabled, they could have been detected. The low 
number of negative scans does make sense when considering the natural basic/acidic 
distribution of substances, but at the same time it might be a big drawback for coeluting 
compounds.  
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Consequently, 14 scans are an inefficiently high number, which is not justified for simple 
MS² screening, where half the number of scans would be sufficient. On the other hand, 
if half of the scan events are appointed to MS³, 14 scans in total are an adequate 
number. Four MS² scans and four consecutive MS³ scans would be available for each 
positive full scan, and two plus two in negative mode (Fig. 10). 
ToxID identified only 7 substances - caused by discordances with the parent mass list 
and library, as explained later on (4.4). 
 
4.2.2.2 Method B (Fig. 7) was chosen to show the effect of very few scan events per 
cycle. It is built up of six scans in total and the approximate full scan to full scan cycle 
time (6 x 0,25 sec) is 1,5 seconds. The full positive scan is followed by three and the full 
negative by one DDA scans. Naturally, only the four most abundant signals (three in 
positive mode, one in negative mode) were taken for fragmentation. Therefore, only 
four compounds were identified manually. Four and three compounds resp. could be 
identified by ToxID, one of them being metoprolol as it appeared in one scan as the 
most abundant ion in one single scan.  
This method could only be applied with very strict DE settings, and via HPLC. Having a 
full scan every 1,5 seconds can be an advantage if the peak width is very narrow, but 
compounds with low intensity will hardly be chosen for fragmentation. Noise and 
especially isotopes of higher abundant molecules are often selected instead. For 
example, one isotope of methadone showed the third highest abundance (m/z 310 - 
methadone and m/z 311) in most full scans. The isotopes should be excluded from 
screening, e.g. by wider exclusion mass range for DE (m/z 2 instead of 1), but this might 
at the same time exclude other analytes. This phenomenon did not occur in all 
experiments with precedent HPLC. 
 
4.2.2.3 Method C1 and C2 (Fig.8) were directly modified based on the method 
recommended by Thermo Fisher Scientific (Rezai, Kozak et al. 2007). Rezai et al. 
suggests the application of eight scan events in total. An additional DDA negative scan 
was included as the original method contained only one. However, three compounds of 
the Testmix ionized in negative mode. Therefore, especially without HPLC or DE, more 
than one scan was needed. In general, two DDA scans can be a great advantage, as 
interferences are always worse for negative ionization. The increase in time 
consumption is not relevant, especially if the DDA scans are confined to a parent mass 
list.  
Therefore, method C was built up of nine scan events, where the full positive scan is 
followed by five DDA scans, and the full negative scan by two DDA scans.  
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In method C2, DE was enabled. This enhanced the method significantly and nine instead 
of just four analytes could be identified. The following parameters (Tab. 11) were 
primarily applied:  
Repeat count 2 
Repeat duration 10,0 sec 
Exclusion list size 25 
Exclusion duration 60 sec  
Tab. 11: DE settings for method C2 
The repeat count was set to two to guarantee doubtless results. The repeat duration 
was of little importance since the mix was directly and continuously infused for five 
minutes (5 µl/min), the exclusion list size was sufficient because there were only 13 
neat standards included. The exclusion duration was chosen because the substances 
should be continuously rescanned within the five minutes. This does not represent 
realistic conditions considering combination with HPLC, but that was not the aim of this 
experiment.  
THC, phenobarbital, BZE-d₃ and ibuprofen were not found due to problems with the 
library (4.4). It is very likely they would have been detected with method C2, if properly 
included. That would make C2 the only method suitable for screening with direct 
infusion. However, even for neat standard solutions or non organic samples (e.g. 
compounds in tablets) HPLC would be a great advantage. Direct infusion can only be a 
tool for certain analytical questions but not for profound STA. However, most general 
principles concerning DDA, threshold, parent mass list, etc apply to methods with and 
without LC in a similar way. 
Methods C1 and C2 were consequently used as standard screening methods for most of 
the hyphenated LC-MS methods. Further consideration had to be put to all questions 
resulting from the chromatography. At the early stages, the parent mass list was 
adapted to compensate for problems evolving from HPLC, such as the RT dependent 
parent mass list. Different DDA and DE approaches were tested and the importance of 
the threshold was evaluated.  
4.2.2.4 “nth Order Double Play” (Fig. 9) Xcalibur offers an additional approach to 
GUS with the this method, besides the introduced C1/C2 method. Full scan to full scan 
cycle times could be decreased significantly (average 0,15 sec/scan). This method only 
works in either positive or negative mode and consists of only two scan events. The first 
is a full scan and the second is a data dependent scan, which can be set for up to 10 
ions. These are then selected as usual depending on the parent mass list or the relative 
intensities. This method is the fastest method available in Xcalibur. The highest number 
of scans/run was achieved (5300/12min), with a full scan to full scan cycle time of only 
1,48 sec. The regulation options are more limited than with other method setups. As 
the method is considered to be built up of only two scan events (the second of which is 
repeatedly performed), the DDA scan features can only be set once. Therefore, NCE, 
parent mass or reject lists, activation time or additional microscans cannot be adapted 
36 
 
individually. This is of little relevance as all DDA scans usually have a common setup. 
However, no MS³ scans can be added and the restriction to a single ionization mode can 
be a time consuming drawback.  
4.3. Special Features 
 
4.3.1 Parent Mass List/Precursor Mass List 
For the pre-selection of ions in multi-target screening, a precursor mass list had to be 
written (syn: parent mass list in Xcalibur). Two general approaches to parent mass list 
setup were tested. First, the list from the ToxID software was used, containing all 
precursor masses of approximately 350 small molecules (drugs and pharmaceuticals) in 
the library. The list usually links substances to certain RTs, meaning that a certain m/z 
will only be selected if it occurs within the right timeframe. This can also be called a 
scheduled scan. For the direct infusion and early HPLC experiments the RT frame was 
irrelevant, and was therefore set from 0-12 minutes. Second, a list including all masses 
from m/z 128 to 500 was created to simulate a GUS without pre-selection. In the library 
128 is the lowest m/z value and only 4 substances have a higher mass than 500. Masses 
above this value have low significance for small molecules analysis and have therefore 
been neglected. If a library is big enough to actually have a corresponding spectrum to 
each of these masses, the focus has to be put on the chromatography and limiting 
timeframes. A list containing all precursor masses from 128-500 produces a lot of MS² 
spectra from noise which do not lead to identification. The rejection of certain masses 
within a certain timeframe (e.g. a known contaminant or matrix component) is also 
available through a reject mass list. Unlike DE it does not bear such a high risk of 
excluding relevant ions, because the lists should be composed mutually. Ions are not 
excluded anywhere during the whole run but within a small timeframe. 
 
4.3.2 Data dependent acquisition 
Problems with the DDA settings include the number of scan events and the triggering 
criteria. Masses can be chosen from a list or via the intensities, without the restrictions 
of a list.  
The number of scans per cycle should be chosen considering to the speed of the LC and 
MS. Too many scans in one cycle can make the overall cycle time to long. While 
fragmenting noise, upcoming relevant precursor masses might be missed. Short cycle 
times decrease that risk, but even with very sensible exclusion settings, substances with 
low intensity may not be detected. However, with only three DDA scan events, only the 
most abundant masses are taken into consideration. Very short cycles might be an 
advantage for UHPLC or other very fast LC methods. On the other hand are 14 scans 
also realistic because the cycle time is still acceptable, especially with fast MS. The 
importance of positive and negative scans has to be considered similarly to the methods 
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without LC. The majority of toxicologically relevant small molecules ionizes only or 
primarily in the positive mode. The scans should be assigned accordingly.    
Techniques for DDA regulate whether a subsequent MS²/MS³ scan is triggered from a 
full scan. Predefined criteria direct this work process towards interpretable results. The 
acquisition process is restrained by a certain threshold and can be enhanced via DE.  
In general, scans are triggered by intensities. Any mass has to exceed a given threshold. 
Furthermore, it has to be either the full scan’s most abundant mass, or the most 
abundant mass from a specified list. An addition to the parent mass list approach is the 
“most intense if no parent mass found” option. This would detect substances not 
included on the list if their abundance is high enough. However the spectra would have 
to be analyzed manually. This can of course be of advantage if reference spectra are 
included at a later date, making retrospective analysis possible. Compounds not 
included in the list and only present at low concentrations will still escape the detection. 
The general aim should therefore be a very large and well established library, combined 
with the “most intense if no parent mass found” function. If MS³ scans are also used for 
identification, the option can be disabled. In this case, the analytes are identified with 
MS², and MS³ is used to confirm the results. However, if identification via MS² is not 
possible, the MS³ spectrum will not be included in the library either. For this process, 
valuable time is wasted. Besides, not every ion produces detectable fragments in MS³. 
With a high-quality library, the pre-selective approach should be preferred, as all taken 
spectra can be processed and identified. When only small libraries are available, 
screening via intensities would be performed, as most relevant ions should be present 
in sufficient concentrations after proper sample workup, and spectra can be manually 
analyzed by trained personnel. The retrospective analysis might be a good approach for 
further development of libraries but it is probably no option for clinical toxicology, 
where the parent mass list approach is preferred.  
 
4.3.3 Threshold 
The LTQ Velos can produce spectra even with a very low number of ions, allowing to set 
a threshold as low as a hundred counts. When setting the threshold, it should be 
considered that analytes can be present in very low and very high concentrations, 
besides the strongly interfering matrix. The abundance of the pseudo-molecular ion will 
not only depend upon it’s actual concentration in the sample, but also very much upon 
the efficiency of the ionization. This process is individual. Two components can be 
present at the same concentration in the body but only one might be detected. A higher 
threshold can of course exclude important analytes but can also prevent the method 
from fragmenting noise. Samples will always contain interfering ions with the same 
precursor mass as relevant analytes, especially under the use of large libraries. 
However, the evaluation of the actual threshold should be performed with real matrix-
containing samples, and might have to be adapted for each matrix specifically.  
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4.3.4 Dynamic Exclusion 
DE is a very helpful tool to make the most of all methods. It is needed to find 
components with very low abundance, as the selection of ions for fragmentation is 
always based on intensities - if possibly confined to a list. Applying DE to any method is 
a very delicate task; it can enhance any method or completely annihilate it. If a certain 
m/z is excluded to soon, a substance cannot be identified correctly. This happens if 
matrix components have the same m/z as an analyte. Moreover if the peak width is 
rather large and ions are selected for fragmentation at an early stage with low 
abundance of the ion, unstable spectra may result, which do not allow identification. 
This can be avoided by setting a sensible threshold.  
Four DE parameters can be adjusted; hereby the aim of any specific method has to be 
considered. Changes in repeat count, repeat duration, exclusion list size and exclusion 
duration have varying impact on the screening. The exclusion list size is the only 
parameter with no influence on the screening. It should be large enough to guarantee 
the full length of exclusion time for any analyte. The factors with direct influence are 
the average peak width, the amount of scans needed for a reliable result and the 
signal/noise ratio.   
Interferences are a big challenge for screening but should mostly be addressed by 
means of sample preparation. In neat standard solutions, noise should not be a 
problem. With biological matrix the interferences can be significant. The benefit of DE 
for neat solutions and clean samples is rather low. For running the 13 components of 
the Testmix via HPLC, DE was often obstructive and therefore disabled for all 
experiments, except those chosen to investigate DE. For example, after exclusion of a 
certain ion prior to elution of an analyte with the same m/z, the spectrum of the analyte 
was not recorded. Furthermore, to see how often one analyte is chosen by DDA across 
the peak, the work process had to run unhindered.  
The average peak time in the described system is approximately 20 seconds. For 
components at very low concentrations such as THC peak time is only about 10 seconds. 
Considering the overall scan cycle time, only one or two scans are made of such a 
substance. Identification from one spectrum is possible, but not as reliable as e.g. from 
4 scans. If only one scan is performed of a certain m/z, a second run should be 
performed for confirmation. Excluding a component after two scans can be necessary if 
the number of compounds in a sample is very high, but it is risky. In some cases, two 
scans were not sufficient for proper confirmation. Especially if the first scan is 
performed immediately after the peak begins to rise, the abundance of the compound 
might not be high enough for a reproducible spectrum. That would leave only one scan 
for comparison before exclusion. If any interfering ion has the same m/z as an analyte, 
this particular m/z could be excluded before the peak elutes. The peak can therefore 
not be assigned correctly; analytes might even be missed completely. The number of 
repeat counts should therefore be evaluated and chosen according to the matrix and 
peak width. Tab. 12 shows how many full cycles fit into one peak. The peak width is 
assumed with 20 and 10 seconds, respectively.  
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Cycle time/ peak width 20 sec 10 sec 
Method A   3,5 s 5,7 2,85 
Method B   1,5 s 13,3 6,67 
Method C   2,25 s 8,8 4,44 
Nth Order double play 1,48 s 13,5 6,75 
Tab. 12: Number of full scan to full scan cycles across one peak 
Two scans before exclusion are the minimum; however, a higher number would be 
favorable. Moreover, if much interference occurs, the repeat count has to be chosen 
lower than for clean samples (e.g. two vs. four). In general, interference in negative 
mode is generally more severe and disturbing. The relevant ions often “disappear” 
among the noise. Hence, the ion is visible in the full scan, but will not be taken for 
fragmentation within two scans (Method C, five DDA positive scans, two DDA negative 
scans) because it is not among the most abundant (provided no parent mass list is 
used). For the 4 most intense ions to be excluded, four full scan to full scan cycles have 
to be completed (DE as shown above for method C2; 2 repeat counts). 14 seconds (3,5 
sec x 4 cycles) can already be too long for smaller peaks, especially considering bad 
efficiency of ionization in negative mode (e.g. ibuprofen). Therefore, a parent mass list 
is a great advantage as only relevant ions are chosen for fragmentation. The risk for 5 
relevant ions to coelute is very small. In such cases, the chromatography has to be 
improved.   
Wissenbach et al. (Wissenbach, Meyer et al. 2011) show a sensitive approach to DE with 
2 repeat counts within 15 seconds and exclusion duration of 15 seconds. They state 
their average peak width of approximately 30 seconds, which allowed for any ion to be 
analyzed at least twice per peak. For the default method C on the LTQ Velos the DE 
settings should therefore be as given in Tab. 13 (average peak width 20 seconds). 
Repeat count 2 
Repeat duration 10,0 sec 
Exclusion list size Not relevant 
Exclusion duration 10 sec  
Tab. 13: DE settings for method C2 
A simpler approach is the application of DE only to eliminate known disturbing 
components, such as endogenous cholesterol. A high number of repeat counts (e.g. 8 
counts within 30 sec) excludes only very prominent ions or wide peaks. The exclusion 
duration can be over a minute, possibly two or three. Of course this would exclude 
possible coeluting analytes with the same m/z.  
The more promising alternative is the use of the “reject list”. Again, if the matrix 
includes known interferences, they can be excluded from screening. Moreover this 
exclusion can be limited to a certain timeframe. 
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Additionally, an early expiration option can be chosen. If a certain mass occurs too often 
during it’s exclusion duration, it is included again before the time ends. 
 
4.3.5 Additional MS³ Scans/Higher Order Scans 
It was also investigated if additional MS³ scans could enhance the screening quality. 
When a spectrum contains only one significant product ion, even with Wideband 
activated, the information is low. Here, a MS³ spectrum may enhance the results. This 
might also help to differentiate between two co-eluting substances. Three general 
method setups are shown under 3.2.3.2. 
In method A half of the positive scan events were transformed into MS³ scans. Thus, in 
positive mode the full scan is followed by four DDA MS² scans and four consecutive MS³ 
scans to confirm the obtained information. This can be an advantage for very simple 
spectra (e.g. one single product ion peak). Furthermore, it can aid to distinguish 
between two analytes, if a mixed spectrum from 2 precursor ions of the same mass is 
obtained.  
There are two ways of determining which ion from the MS² scan is selected for the 
subsequent MS³ scan. Similar to MS² screening, the “most intense” ion or the “most 
intense ion from the list” can be selected. 
The “most intense ion” to collects MS³ data for every MS² scan, from the most intense 
of the original MS² fragments. This is time consuming, especially for ions not producing 
an MS³ spectrum. Due to variation in intensities of the fragments (especially if two 
fragments are nearly equally abundant), the wrong precursor might be chosen for MS³, 
making an identification impossible, maybe even leading to a false negative result. This 
phenomenon was observed, for morphine-d₃. At the rise of the peak the abundance of 
the ion was very low and the spectrum randomly varied in intensity ratios. The 
produced spectrum was not identified. However, a second spectrum was produced later 
on the same peak. This spectrum was more stable, the overall abundance higher and 
the ratios were therefore correctly correlating with the library spectrum.   
The parent mass list had to be expanded by the MS³ precursor ions; hence a combined 
MS² and MS³ parent mass list was used. Substances not producing an MS³ spectrum can 
be neglected. Unfortunately, all masses included for MS³ scans are also available parent 
masses for MS² scans, as they are combined in one list. This makes the selection less 
precise, as noise might be chosen for fragmentation because an MS³ ion has the same 
m/z. Improvement could come from scheduled scanning. 
A third approach is to make changes in the parent mass list, instead of in the method 
setup. Hereby, all scan events are designated MS² scans. However, on the global parent 
mass list, the m/z of MS² fragments are assigned to their specific precursor. Xcalibur 
allows this up to MS³ only. Treatment with individual collision energy for certain 
substances is also possible, but MS² data is lost for the selected precursors. If a certain 
ion is included into the list twice (e.g. morphine-d₃ with 289,0 and 289,1), MS² and MS³ 
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data are available but the handling of the list becomes more laborious - one of the 
major drawbacks of Xcalibur.  
A schematic image of the Parent mass list is given in Tab. 14. 
Mass Retention time MS² precursor CE Name 
289 0,5-1,5min 144 40% Morphine-d₃ 
289,1 0,5-1,5min   Morphine-d₃ 
Tab. 14: Global parent mass list in Xcalibur, schematic image 
Unfortunately, the search interface ToxID was only able to identify spectra taken with 
designated MS² and MS³ scan events (e.g. method A), with the “most intense ion from 
the list” approach. In general, ToxID allows a search for MS², MS³ or combined 
MS²&MS³ spectra, respectively, if taken with the correct method. The search interface 
SmileMS on the other hand performs the library search with one of the three above 
mentioned approaches.  
Apart from the above mentioned methods, an approach where the MS³ scan is only 
triggered when needed, without losing MS² information and without generating a great 
amount of extra work would be desirable.  
 
4.4 The Spectral Library 
 
The quality of the spectral library is of utmost importance for the quality of the 
screening. Problems with transferring libraries between different laboratories or 
instruments have been the major drawback for LC-MS. Would the ionization process be 
as stable as with EI in GC-MS, LC-MS might already be the new gold standard for 
forensic toxicology. Features such as NCE or Wideband have significantly enhanced the 
reproducibility, although not to the same level as EI. The largest libraries available for 
LC-MS include up to 1500 substances, the largest library for GC-MS contains over 
200.000 entries –including metabolites and adducts.1500 substances certainly cover 
most incidents and serve most needs; however, especially in forensics the unexpected 
and even very unlikely always has to be considered. 
Spectra can differ to a variable degree when taken under alternating conditions, other 
instruments or matrices. Next to spectrum creation, the library management and search 
process is equally important. Before the development of “Stepped Collision Energy” 
(Thermo Fisher Scientific) or “Collision Energy Spread” (AB Sciex) a common approach 
was the inclusion of more than one spectrum per substance at different collision 
energies. These spectra were either saved separately or reconstructed to one spectrum 
(Sauvage, Saint-Marcoux et al. 2006). It has to be underlined that spectra produced in 
an Ion Trap cannot be compared to those recorded in a quadrupole collision cell due to 
the different ways of fragmentation. Libraries for high resolution single MS experiments 
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can even consist of theoretical data only as they represent the exact masses. Only data 
about RT or fragmentation has to be determined experimentally. 
Thermo provides a 329 component library with the “ToxID” software. However, not all 
of the settings for recording the spectra for “Tox_Library” are stated. Upon inquiry, the 
settings were provided. Following conditions had been applied:  
 
 Solution concentration: 10 mg/L  
 Solvent mixture: 70:30 of H₂O with 10mM ammonium formiate and 0.1% 
formic acid; and ACN with 0.1% formic acid  
 Flow rate: 10 µL/min;  
Information provided in the library is rather poor. No synonyms, CAS-number, structure 
or molecular formula and no information about the instrument or the solvent for 
recording the spectrum are given. Upon inquiry, spectrum creation at different 
instruments (LCQ, LXQ and LTQ) was disclosed and Thermo stated that due to the 
different geometry of the traps, the NCE needed can differ from default (35%). 
Therefore, the LTQ Velos might need slightly more NCE (e.g. 40%). This was ultimately 
adopted for the default method. When comparing the different NCE, especially when 
SCE is enabled, the differences between spectra do not significantly influence the 
search results, although individual spectra may vary more. It can be assumed that the 
spectra might not be comparable between traps of different manufactures. 
Much more discrepancy originates from the HPLC method. When developing a new 
method, all RT included in the library have to be checked and validated as the search is 
strongly dependent upon RT. RT are strongly dependent upon the used column, solvent, 
and other factors. This issue will be more closely discussed under 4.6 HPLC.  
The solvent mixture is of relevance as the spectra vary between neutral (e.g. methanol) 
or acidic solvents (with glacial acid, formic acid), and between sources and instruments. 
Spectra were well comparable after adaption of activation settings. In general, spectra 
produced by direct infusion always bear the potential risk of varying from the ones 
taken via HPLC. An example for this phenomenon is given below (Fig. 14). The upper 
spectrum of THC was taken in methanolic solution (direct infusion) while the lower 
spectrum was from the library. This may be due to the missing H⁺ ions needed for 
ionization. However, the abundance of these spectra is equal (9,99 E2 = 9,99*10²). 
Spectra to be included in the library should therefore be taken under conditions as close 
to the actual method as possible.  
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Fig. 14: THC spectrum in methanolic solution and Tox_Library spectrum 
 
4.5 Screening Software: SmileMS vs. ToxID 
 
Two available screening software packages were assessed. SmileMS (GeneBio) and 
ToxID (Thermo Fisher) were both used to process collected data and search the 
available library (Tox_library, Thermo Fisher). Besides the issues mentioned above, the 
two software packages were evaluated for their practicability and applicability.  
In ToxID, all spectra are included in an excel sheet. The parent mass, one product ion 
mass, intensity threshold, Search Index (SI) and Reverse Search Index (RSI) have to be 
entered individually. While this enables unique criteria for each substance, the handling 
of the excel sheet is strenuous. There is no automatic update option for new library 
entries and no feature to easily manage and change data sets. Upon inquiry no easier 
solution to manage data and no convenient interface to run screenings could be 
provided. Additional search criteria can only be applied for each search request 
specifically. In the ToxID “setup” page the search can be limited with regard to m/z and 
RT. The software then produces a report showing all identified substances. For each 
substance, all scans which match a library entry are listed on a chromatogram. 
However, only the scan with the highest abundance is shown in the “Long Report” and 
can be checked manually. Beyond that, no further intervention or review of the results 
is possible. The program Xcalibur contains a library manager which allows manual 
analysis of spectra. 
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SmileMS allows the user to review the data and adapt exclusion parameters before 
creation of the report. All matching spectra are available for manual check. Moreover, 
SmileMS has a “library manager”, which can import any number of libraries from 
different providers. It saves all associated spectra under the name of the corresponding 
compound. MS² scans as well as MS³ lead to the same entry. Apart from these more 
sophisticated features, the visual appearance is more appealing and the handling more 
user-friendly. 
 
4.6 HPLC  
 
The optimization of the conditions for the liquid chromatography was not the aim of 
this work. To develop a full LC-MS screening method however, chromatography is of 
great importance. The type of column, the solvent composition, the runtime, flow rate 
and gradient etc. have to be considered. Stability, robustness and other factors have to 
be tested. The establishment of a stable system would have gone beyond the scope of 
this work. However, some thoughts into fundamental issues concerning 
chromatography are compiled here. As the identification of substances always depends 
upon RT, shifts can be a problem. A possible system to predict the shift of analytes with 
an Excel calculation was developed (3.2.4.1). 
For the 13 substances of the Testmix a shift in RT simulated by a flow of 0,4 ml/min 
instead of 0,3 ml/min was well predicted (Tab.15; Fig. 15) linear behavior was assumed.  
 
Tab. 15: Original RT (0,3 ml/min); Calculated RT (0,4 ml/min); Measured RT (0,4 ml/min) 
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Fig. 15: Linearity of RT shifts; blue: calculated trend; green: measured values 
 
4.7 Limit of Detection - Pretests 
 
In order to support future limit of detection evaluations, pretests were run at different 
dilutions. The components of the Testmix were originally present at different 
concentration levels: 5µg/ml, 50µg/ml and 500µg/ml, respectively, as mentioned under 
Material and Methods (3.2.5). The Solution was diluted 1:10, 1:100 and 1:1000.  
The applied method was method C. Threshold was set to 100 counts, and DE was 
disabled. All components could be identified up to a dilution - factor of 1:100. The 
search index and reverse search index (criteria for the matching with the library spectra) 
did not decrease with the lower concentration, although less scans were performed for 
each substance and therefore less information was available to confirm identification. 
Amphetamine was the substance with the lowest counts (222), followed by THC (418 
counts). The threshold of 100 counts is presumably too low for matrix-containing 
samples. One component had an intensity over 1000 (ibuprofen 1717 counts) and all 
others were far over 10.000 counts.  
At 1:1000 only seven components were identified, with phenobarbital and morphine at 
2761 and 3631 counts, respectively. All other identified components showed over 
10.000 counts. The TIC (Fig. 16) does not show the significant peaks anymore, only 
methadone still had a very good signal/noise ratio. The substances were still identified 
because they were included in the parent mass list.  
46 
 
 
Fig. 16: TIC of the 1:1000 dilution 
 
Substance Orig. conc 1:10 1:100 1:1000 
Amphetamine 0,05mg/ml   - 
Benzoylecgonine-d₃ 0,05mg/ml    
Cocaine 0,05mg/ml    
Codeine 0,05mg/ml   - 
Diazepam 0,05mg/ml    
Doxepine 0,05mg/ml    
Ibuprofen 0,5mg/ml   - 
Methadone 0,05mg/ml    
Metoprolol 0,05mg/ml   /- 
Morphine 0,05mg/ml    
Phenobarbital 0,5mg/ml    
THC 0,005mg/ml   - 
THCCOOH 0,005mg/ml   - 
Tab. 16: LOD of Testmix components; original concentration in the Testmix, and detection via ToxID in 
dilutions: 
Without the list, the identification would probably not have worked at the lowest 
concentration, similar to matrix-containing samples. The negative scan events show the 
need for a list as well. The molecular ion of phenobarbital (m/z 231) elutes around 4.4 
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minutes but it is selected for fragmentation during the whole twelve minute run. 
Although m/z 231 disappears among the noise before and after the peak, it is still 
selected because the ions included in the list are preferred.  
The limit of detection does not correlate directly with the concentration of the analyte, 
as the ionization behavior has great impact. As an example, ibuprofen was present in 
higher concentrations than methadone but was not detected in the 1:1000 dilution.  
 
4.8  Real Samples  
 
4.8.1 Powder 
A brown powder which was initially sold as heroine was analyzed by HPLC-DAD. Strong 
evidence was found for alprazolam, paracetamol, caffeine, and brucine. The sample was 
then analyzed by LC-MS (Method C) and additionally by GC-MS and LC-QqTOF-MS.  
Since the library did not include the very uncommon component brucine (Fig. 17) 
initially, the search was not limited by the parent mass list but rather with the 128-500 
approach. After analyzing a brucine/quinine standard (1mg/ml in MeOH) and adding 
MS² and MS³ spectra to the library, the spectra were manually compared and the 
results confirmed (App. 9). 
 
Fig. 17: Brucine 
Knowing the molecular weight of brucine, MS² was performed on the specific mass of 
the standard and the sample in the same way (App. 10), leading to semiquantitative 
results. Brucine was found at approx. 100mg/g (UV/VIS: 104mg/g), an unexpected result 
for a heroine sample.  
Additionally to brucine, alprazolam, paracetamol and caffeine, phenolphtalein was 
detected in LC-MS and GC-MS. Domperidone was only detected in LC-MS. Traces of 
strychnine were only found in GC-MS. High resolution data confirmed these results. 
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4.8.2 Urine  
The urine of a patient with suspected ecstasy intoxication was diluted 1:1000 and 
analyzed with Method C (no DE, parent mass list from 128-500, RT frame from 0-12). 
Based on the results of HPLC-DAD and comparison with the library the unknown 
compound was identifies as the designer drug 4-Methylethcathinone (4-MEC; Fig.18) 
 
Fig. 18: 4-Methylethcathinone 
Following components were identified via LC-MS: amiodarone, fentanyl, furosemide, 
lidocaine, midazolam and nicotine. An additional, high abundant peak was found at 1.4 
minutes. As the substance was not included in the Tox_Library, a reference substance 
(indicated by the prior HPLC-DAD analysis) was used for identification. The data given in 
the appendix (App. 11) shows the total ion chromatogram of the urine as well as the full 
MS of the unknown peak (App. 12), showing a high abundant peak at 192 [M+H⁺]. The 
chemical formula of 4-MEC is C₁₂H₁₇NO with a nominal mass of 191. 
For analysis by GC-MS, the sample was extracted (liquid-liquid) with Dichlormethan, pH 
8 and additionally acetylated or silylated. The component was confirmed as 4-MEC.  
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5 Abbreviations 
 
ACN  Acetonitrile 
AGC  Automatic Gain Control 
API  Atmospheric Pressure Ionization 
APCI  Atmospheric Pressure Chemical Ionization 
BZE   Benzoylecgonine  
CE  Collision Energy 
CID   Collision Induced Dissociation 
DAD  Diode Array Detection 
DDA   Data dependent Acquisition 
DE  Dynamic Exclusion 
EMA  European Medicines Agency 
EPI  Enhanced Product Ion 
ESI  Electrospray Ionization 
GUS   General Unknown Screening 
HPLC  High Performance Liquid Chromatography 
ICH  International Conference on Harmonisation 
IP  Identification Points 
LIT  Linear Ion Trap 
MeOH  Methanol 
MRM   Multiple Reaction Monitoring 
MRFA  L-methionyl-arginyl-phenylalanin-alanin acetate * H₂O 
MS  Mass Spectrometry; Mass Spectrum 
NCE  Normalized Collision Energy 
PI  Product Ion 
PFP   Perfluorophenyl 
50 
 
QqLIT  Quadrupole- Linear Ion Trap hybrid 
QqQ  Quadrupole, here: Triple Quadrupole 
RT  Retention Time 
SCE  Stepped Collision Energy  
SIM   Selected Ion Monitoring  
SRM   Selected Reaction Monitoring  
STA  Systematic Toxicological Analysis 
TIAFT  The International Association of Forensic Toxicologists 
TIC   Total Ion Current/Total Ion Chromatogram 
THC  Delta-9-Tetrahydrocannabinol  
THCA  11-nor-9-Carboxy-THC 
TOF   Time of Flight detector 
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8. Appendix  
 
App. 1: Two Metoprolol Spectra (red and blue) taken in one run, across the peak, with the default method (40% ± 10%NCE; 30 ms) 
 
App. 2: Metoprolol spectra taken at NCE 35% (blue) vs. 40% ± 10% (default, red) 
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App. 3: Morphine-d₃ taken at 10 ms activation time (blue) and 30 ms activation time (default, red) 
 
App. 4: Morphine-d₃; taken at 50 ms activation time (blue) and 30 ms activation time (default, red) 
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App. 5: Methadone-d₃ spectra taken at NCE 35% (blue) and 40% (red) 
 
App. 6 :Morphine-d₃, three MS³ spectra taken with 10 ms activation time across the peak (RT 0,84 min) 
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App. 7: Morphine-d₃, three MS³ spectra taken with 30 ms activation time across the peak (RT 0,84 min) 
 
App. 8: Morphine-d₃, three MS³ spectra taken with 50 ms activation time across the peak (RT 0,84 min) 
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App. 9: Spectrum of brucine in powder sample (4.8.1) and Tox_Library spectrum 
 
App. 10: Total ion chromatogram of brucine (MW: 394,47) 
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App. 11: TIC of the urine sample containing 4-MEC 
 
App. 12: Full mass spectrum of the peak at 1,3 min 
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Internal Standard methods               
3standards y 12 1 3 MS2 n  75-350 40 30 +    
3standardsB y 12 1 3 MS2 n  75-350 40 50 +    
3standardsC y 12 1 4 MS2 y  75-350 40 30 +    
Testmix methods               
GUS_DD012a n 3 1 14 DDA y +10-2 default 35 30 + 012   
GUS_DD y 12 1 9 DDA y +5-2 default 35 30 + default   
GUS-DD012b n 3 1 6 DDA y +3-1 default 35 30 + 012   
GUS-_DD_012step y 12 1 9 DDA y +5-2 default 35 30 + 012 y  
GUS_DD_012stepDE y 12 1 9 DDA y +5-2 default 35 30 + 012 y 5/10/50/30 
GUS_DD_01240step y 12 1 9 DDA y +5-2 default 40 30 + 012 y  
GUS_DD_01245 y 12 1 9 DDA y +5-2 default 45 30 + 012 n  
GUS_DD_01245step y 12 1 9 DDA y +5-2 default 45 30 + 012 y  
GUS_DD_02040step y 20 1 9 DDA y +5-2 default 40 30 + 020 y  
GUS_DD_RT y 12 1 9 DDA y +5-2 default 40 30 + default y  
GUS_DD_RTDE y 12 1 9 DDA y +5-2 default 40 30 +  MS³ y 2/5/50/10 
GUS_DD_testlist012 y 12 1 9 DDA y +5-2 default 35 30 + 012 n  
GUS_DD_testlist012Her1 n 5 1 9 DDA y +5-2 default 35 30 + 012 y 2/15/50/30 
GUS_DD_testlist0120500 y 12 1 9 DDA y +5-2 default 40 30 + 012/128-
500 
y  
GUS_DD_testlist0120500A n 3 1 9 DDA y +5-2 default 35 30 + 012/128-
500 
y 2/15/50/60 
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GUS_DD_testlist0120500AHer2 n 5 1 9 DDA y +5-2 default 35 30 + 012/128-
500 
y 2/15/50/30 
GUS_DD_testlist0120500DE y 12 1 9 DDA y +5-2 default 40 30 + 012/128-
500 
y 2/10/50/15 
Master_RT y 12 4 3/2/2/5 MS2 n  70-350 40 10 +  y  
Master_RT_DDA y 12 4 3/4/3/4 MS2 y  75-350 40 10 +   exclparent y  
Methanol n 10 1 1  y + 300-550       
Single Substance Methods               
BZED3 n 5 1 1 MS2 n  80-300 35 10 +  n  
BZED3_1 n 5 1 4 MS2 n  85-350 30/40/50 30 +  y  
Delta9THC n 5 1 3 DDA/MS2 y +1/MS2 85-350 40/35 30/10 +  y  
Delta9THC2 n 5 1 4 MS2 y  85-350 30/40/50 30 +  y  
Diazepam n 5 1 1 MS2 n  75-300 35 10 +  n  
Diazepam_1 n 5 1 4 MS2 y  75-350 30/40/50 30 +  y  
Ibuprofen n 12 1 2 MS2 y  55-250 35 10 +  y  
Ibuprofenb n 5 1 4 MS2 y  55-250 35 10 +  n  
MetDia n 5 1 3 MS2 y  70-300 35 10 +  n  
MetDiaB n 3 2 3/3 MS2/DDA y MS2+/+2 70-300 40 10 +  y  
MetDiaC n 2 1 3 DDA y +2 70-300 35 10 + exclParent n  
MethadonD3 n 5 1 1 MS2 n  85-350 35 10 +  n  
Metoprolol n 5 2 1/1 MS2 n  70-300 35/40 10 +  n  
MetorprololDIL n 5 1 1 MS2 n  70-300 35 10 +  n  
Metorprolol_1 n 5 1 4 MS2 y  70-350 30/40/50 30 +  y  
Morphin n 5 1 4 MS2 y  75-350 30/40/50 30 +  y  
MorphinD3 n 5 1 3 MS2 y  75-350 40 10/30 +  y  
Phenobarbital n 5 1 4 MS2/3 y  50-300 40(20/40) 30/10 +  y  
MS3 Methods              DDA 
GUS_MS2_3 y 12 1 14 MS2/3 y +4/4-2/2 default 40 30 - default y MI 
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GUS_MS2_3w y 12 1 14 MS2/3 y +4/4-2/2 default 40 30 + default y MI 
GUS_MS2_3w_A y 12 1 14 MS2/3 y +4/4-2/2 default 40 30 + default y MI - fL 
GUS_MS3 y 12 1 9 MS3 (2) y  default 40 30 + MS3 in List y  
App. 13: Methods used for different experiments 
Step: always 20%, 3steps;  
Range: default = 128-827.4 
DDA Scantype: +/-: full pos, full neg scan, numbers give the amount of according DDA scans.   
Parent list features:  
default list: list with all parent masses, including correct RT, seperate pos/neg   
128-500: For simulation of GUS, all masses from 128-500 included (small molecules range) 
012: referring to RT frame, set from 0-12 minutes, therefore no scheduled scans.  
exclparent: exclusive parent list, only specified precursor masses included  
DDA: triggered by: MI: Most Intense, MI - fL: Most Intense from List 
 
 
21.07.2011       
Testmix A B C D E F 
Morphine 0,84 0,83 0,84 0,84 0,84 0,84 
Amphetamine 1,75 1,75 1,745 1,76 1,75 1,76 
Codeine 1,89 1,94 1,88 1,92 1,88 1,92 
BZE-D3 4,04 4,04 4,1 4,08 4,02 4,04 
Phenobarbital 4,44 4,46 4,45 4,515 4,43 4,45 
Metoprolol 5,16 5,17 5,16 5,175 5,15 5,17 
Cocaine 5,56 5,57 5,575 5,585 5,59 5,57 
Doxepin 6,35 6,32 6,335 6,365 6,35 6,32 
Diazepam 6,35 6,32 6,385 6,39 6,39 6,4 
Methadone 6,75 6,76 6,7 6,765 6,74 6,75 
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THCA 7,05 7,02 7,03 7,04 7,04 7,05 
THC 7,56 7,57 7,56 7,56 7,55 7,75 
02.09.2011     16.09.2011  
Testmix G H I J K L 
Morphine 0,82 0,87 0,85 0,86 0,84 0,79 
Amphetamine 1,82 - 1,72 1,72 1,75 1,74 
Codeine 2,06 - 1,87 1,96 1,93 1,82 
BZE-D3 4,25 4,05 4,11 4,01 4,09 4,05 
Phenobarbital 4,48 4,38 4,39 4,36 - - 
Metoprolol 5,18 5,19 5,22 5,15 5,22 5,16 
Cocaine 5,66 5,66 5,62 5,6 5,67 5,62 
Doxepin 6,36 6,35 6,35 6,31 6,36 6,34 
Diazepam 6,37 6,35 6,39 6,39 6,39 6,35 
Methadone 6,84 6,82 6,79 6,77 6,78 6,77 
THCA 7,04 - 7 7,02 - - 
THC 7,59 - 7,55 7,55 7,54 7,54 
Ibuprofen 6,53 - 6,51 6,48 - - 
App. 14: RT on three different days for all Testmix components 
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Zusammenfassung 
 
Die Entwicklung neuer Methoden für die Systematisch-Toxikologische Analyse (STA) ist 
ein fortwährender Prozess, sowohl in forensischer als auch in klinischer Toxikologie. Die 
Entwicklung neuer Methoden, basierend auf LC-MS, ist bereits seit mehr als einem 
Jahrzehnt im Fokus der Forschung. Um Routinemethoden zu etablieren, müssen alle 
Faktoren, die ein Screening beeinflussen, bekannt sein. Angefangen bei dem 
Ionisierungsprozess über das Erfassen eines Spektrums bis hin zu der verwendeten 
Referenz-Bibliothek müssen viele Faktoren evaluiert werden. Des Weiteren ist die 
Reproduzierbarkeit und Übertragbarkeit der Spektren ein Thema, für das bisher kein 
völlig befriedigendes Ergebnis gefunden wurde.   
Einleitung: Für die Entwicklung einer Routine Screening Methode wurde eine lineare 
Ionenfalle, in Kombination mit HPLC und der „Tox_Library“ verwendet. 
Hauptaugenmerk wurde auf alle Parameter, die ein Screening beeinflussen, gelegt. 
Dazu gehören sowohl die instrumentellen Parameter als auch die Punkte, die mit der 
Spektrenbibliothek in Zusammenhang stehen. Das Ziel dieser Arbeit war, jene Faktoren 
auf dem verwendeten Gerät zu identifizieren, die beachtet werden müssen, wenn eine 
LC-MS Methode für die Systematisch-Toxikologische Analyse etabliert werden soll.  
Material und Methoden: Das Massenspektrometer “LTQ Velos” (Thermo Fisher 
Scientific) wurde zusammen mit einer RS 300 Ultimate HPLC (Dionex) für diese Arbeit 
verwendet. Ein Testmix aus 13 toxikologisch relevanten Substanzen wurde für 
individuelle Experimente herangezogen. Deuterierte Standards wurden verwendet, um 
Veränderungen im chromatographischen System zu detektieren. Einzelne Substanzen 
oder Substanzmischungen wurden entweder direkt infundiert oder via on-line HPLC 
eingebracht. Vorversuche für Limit of Detection Tests wurden durchgeführt und, um die 
erstellte Methode zu testen, wurden zwei reale Proben analysiert. Die verwendete 
Software für das Sammeln und Verarbeiten der Daten stammt von Thermo Fisher 
Scientific. Das Such-Interface “ToxID” mit der “Tox_Library” sowie der 
Bibliotheksmanager “SmileMS” von Genebio wurden auf ihre Anwendbarkeit hin 
überprüft.  
Ergebnisse und Diskussion: Die Schlüsselparameter für die Erstellung von Bibliotheks-
Spektren und ihre praktische Anwendung werden diskutiert sowie die optimalen 
Einstellungen für die Ionisation bei unterschiedlichen Anwendungen. Eine Auswahl an 
möglichen Methoden für das multi-target bzw. “General Unknown” Screening werden 
beschrieben und stehen für zukünftige Routinemethoden zu Verfügung. Des Weiteren 
werden Probleme beim Screening und beim Erstellen von Spektren für eine Bibliothek 
aufgezeigt: die Anzahl an Scan Events, Daten abhängige Acquisition, Dynamic Exclusion, 
Aktivierungsparameter und die Relevanz der Preselektion von Targets. Die Tox_Library 
und die Suchprogramme “ToxID” und “SmileMS” wurde evaluiert und Spektren für MS² 
und MS³ aufgenommen. 
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